Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales

Steven Kerr, Stuart Bedston, Declan T Bradley, Mark Joy, Emily Lowthian, Rachel M Mulholland, Ashley Akbari, F D Richard Hobbs, Srinivasa Vittal Katikireddi, Simon de Lusignan, Igor Rudan, Fatemeh Torabi, Ruby S M Tsang, Ronan A Lyons, Chris Robertson, Aziz Sheikh

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology